These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24807840)

  • 1. Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies.
    Zhu J; Lin Z; Wu J; Yin H; Dai J; Feng Z; Marrero J; Lubman DM
    J Proteome Res; 2014 Jun; 13(6):2986-97. PubMed ID: 24807840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass Spectrometric N-Glycan Analysis of Haptoglobin from Patient Serum Samples Using a 96-Well Plate Format.
    Zhu J; Wu J; Yin H; Marrero J; Lubman DM
    J Proteome Res; 2015 Nov; 14(11):4932-9. PubMed ID: 26448449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease.
    Peta V; Zhu J; Lubman DM; Huguet S; Imbert-Bismutd F; Bolbach G; Clodic G; Matheron L; Ngo Y; Raluca P; Housset C; Rezai K; Poynard T;
    Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):681-691. PubMed ID: 31964615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass-selected site-specific core-fucosylation of ceruloplasmin in alcohol-related hepatocellular carcinoma.
    Yin H; Lin Z; Nie S; Wu J; Tan Z; Zhu J; Dai J; Feng Z; Marrero J; Lubman DM
    J Proteome Res; 2014 Jun; 13(6):2887-96. PubMed ID: 24799124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass-Selected Site-Specific Core-Fucosylation of Serum Proteins in Hepatocellular Carcinoma.
    Yin H; Tan Z; Wu J; Zhu J; Shedden KA; Marrero J; Lubman DM
    J Proteome Res; 2015 Nov; 14(11):4876-84. PubMed ID: 26403951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESI-LC-MS Method for Haptoglobin Fucosylation Analysis in Hepatocellular Carcinoma and Liver Cirrhosis.
    Zhang Y; Zhu J; Yin H; Marrero J; Zhang XX; Lubman DM
    J Proteome Res; 2015 Dec; 14(12):5388-95. PubMed ID: 26503433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinoma.
    Pompach P; Brnakova Z; Sanda M; Wu J; Edwards N; Goldman R
    Mol Cell Proteomics; 2013 May; 12(5):1281-93. PubMed ID: 23389049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease.
    Sanda M; Pompach P; Brnakova Z; Wu J; Makambi K; Goldman R
    Mol Cell Proteomics; 2013 May; 12(5):1294-305. PubMed ID: 23389048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of serum Haptoglobin using glycoproteomics and lectin immunoassay in liver diseases in Hepatitis B virus infection.
    Dalal K; Dalal B; Bhatia S; Shukla A; Shankarkumar A
    Clin Chim Acta; 2019 Aug; 495():309-317. PubMed ID: 31014754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-linked glycan changes of serum haptoglobin β chain in liver disease patients.
    Zhang S; Shu H; Luo K; Kang X; Zhang Y; Lu H; Liu Y
    Mol Biosyst; 2011 May; 7(5):1621-8. PubMed ID: 21380457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer.
    Lin Z; Simeone DM; Anderson MA; Brand RE; Xie X; Shedden KA; Ruffin MT; Lubman DM
    J Proteome Res; 2011 May; 10(5):2602-11. PubMed ID: 21417406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of AGP Fucosylation as a Marker for Hepatocellular Carcinoma of Three Different Etiologies.
    Liang J; Zhu J; Wang M; Singal AG; Odewole M; Kagan S; Renteria V; Liu S; Parikh ND; Lubman DM
    Sci Rep; 2019 Aug; 9(1):11580. PubMed ID: 31399619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LC-MS/MS isomeric profiling of permethylated N-glycans derived from serum haptoglobin of hepatocellular carcinoma (HCC) and cirrhotic patients.
    Huang Y; Zhou S; Zhu J; Lubman DM; Mechref Y
    Electrophoresis; 2017 Sep; 38(17):2160-2167. PubMed ID: 28543513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum fucosylated haptoglobin in chronic liver diseases as a potential biomarker of hepatocellular carcinoma development.
    Asazawa H; Kamada Y; Takeda Y; Takamatsu S; Shinzaki S; Kim Y; Nezu R; Kuzushita N; Mita E; Kato M; Miyoshi E
    Clin Chem Lab Med; 2015 Jan; 53(1):95-102. PubMed ID: 25060348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma protein biomarkers of hepatocellular carcinoma in HCV-infected alcoholic patients with cirrhosis.
    Ferrín G; Rodríguez-Perálvarez M; Aguilar-Melero P; Ranchal I; Llamoza C; Linares CI; González-Rubio S; Muntané J; Briceño J; López-Cillero P; Montero-Álvarez JL; de la Mata M
    PLoS One; 2015; 10(3):e0118527. PubMed ID: 25789864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma and its early detection by AFP testing in Mongolia.
    Oyunsuren T; Sanduijav R; Davaadorj D; Nansalmaa D
    Asian Pac J Cancer Prev; 2006; 7(3):460-2. PubMed ID: 17059345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; El-Rouby MN; Hammad I; Ahmed EA; Marzouk HA; Nabil MM; Hamed HA; Aly YH; Zachariah KS; Esmat G
    Asian Pac J Cancer Prev; 2015; 16(3):1281-7. PubMed ID: 25735368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Potential Serum
    Higashi M; Yoshimura T; Usui N; Kano Y; Deguchi A; Tanabe K; Uchimura Y; Kuriyama S; Suzuki Y; Masaki T; Ikenaka K
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Predictive Model Using N-Glycan Biosignatures for Clinical Diagnosis of Early Hepatocellular Carcinoma Related to Hepatitis B Virus.
    Cong M; Ou X; Huang J; Long J; Li T; Liu X; Wang Y; Wu X; Zhou J; Sun Y; Shang Q; Chen G; Ma H; Xie W; Piao H; Yang Y; Gao Z; Xu X; Tan Z; Chen C; Zeng N; Wu S; Kong Y; Liu T; Wang P; You H; Jia J; Zhuang H
    OMICS; 2020 Jul; 24(7):415-423. PubMed ID: 32522092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.